Evoke Pharma (EVOK) Misses Q1 EPS by 13c

Evoke Pharma (NASDAQ: EVOK) reported Q1 EPS of ($0.49), $0.13 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Trump discloses over $1.4 billion in crypto income in 2025 filing
• Global-e completes $350M acquisition of Passport logistics firm
• NHC acquires 35 facilities from NHI for $560 million